Skip to main content
EN
Menu

Why NordHealth stock moves

NordHealth was roughly unchanged, an ordinary day for the stock.

Written after the close on ·

Earnings report

Next report: November 10. On its last 9 report days NordHealth usually moved about 2.8%. On a normal day it moves 2.2%.

August 18, 2026: −2.54%August 19, 2025: −2.79%August 20, 2024: −1.45%March 5, 2024: −3.08%

Why today

16,307 news analyzed today

NordHealth was roughly unchanged, an ordinary day for the stock.

Its shares held steady while the Oslo benchmark index fell sharply, so it moved far less than the market.

No company news explains the session.

Over the last five trading days, NordHealth fell clearly, more than the market's sharp drop.

Its results for the third quarter are due on Tuesday 10 November 2026, a date to watch next.

Today's move of +0.00% was 0.0 times a normal day's 2.2%. Oslo Børs benchmark index moved −1.31% on the same day.

NordHealth +0.00%

Earlier days →

See the chart in ChartCompass, with every move explained →

What analysts expect, and how often they have been right

Analysts’ estimates for NordHealth.

Ratings

Now
Buy 1Hold 0Sell 0

A rating is the analyst’s own opinion about the share.

Price targets

Latest price 24.60 NOK

Price targets
32.21

One analyst’s target is 32.21 NOK, +31% relative to the latest price of 24.60 NOK. A target is the analyst’s estimate of a future share price.

For the current fiscal year, expected earnings per share changed from -0.05 EUR three months ago to -0.04 EUR now. 2026 estimate: -0.04 EUR. 2027 estimate: 0.06 EUR. One analyst made these estimates.

What the key figures say about NordHealth

The figures connect what NordHealth earns with what investors pay.

The line shows the share price in the same year, on its own scale. Hatched bars: analysts’ estimates.

Earnings per share-2.32 NOK
NowEarnings per share2022: -0.18222023: -0.14232024: -0.10242025: -0.16252026: -0.04262027: 0.0627

Profit divided by the number of shares. Each share represents this much of the earnings.

2022–2025: -0.18 EUR–-0.10 EUR. Peers: Carasent 0.59 SEK, Aiforia Technologies -0.42 EUR, Physitrack -3.93 SEK. 2026 estimate: -0.04 EUR (-0.04 EUR–-0.04 EUR). 2027 estimate: 0.06 EUR (0.06 EUR–0.06 EUR).

Revenue53.1 m EUR
NowRevenue2022: 31,049,000.00222023: 36,825,000.00232024: 45,675,000.00242025: 50,841,000.00252026: 57,300,000.00262027: 65,700,000.0027

What the company sold during the year.

2022–2025: 31.0 m EUR–50.8 m EUR. Peers: Carasent 390 m SEK, Aiforia Technologies 2.9 m EUR, Physitrack 14.3 m EUR. 2026 estimate: 57.3 m EUR (57.3 m EUR–57.3 m EUR). 2027 estimate: 65.7 m EUR (65.7 m EUR–65.7 m EUR).

Operating margin−28.4%
NowOperating margin2022: -47.28222023: -30.92232024: -16.91242025: -24.5225

The percentage of revenue left after the costs of running the business.

2022–2025: −47.3%–−16.9%. Peers: Carasent 4.1%, Aiforia Technologies −316.4%, Physitrack 6.8%.

Return on equity−25.8%
NowReturn on equity2022: -14.46222023: -13.45232024: -10.42242025: -20.6025

Profit as a percentage of shareholders’ money in the company.

2022–2025: −20.6%–−10.4%. Peers: Carasent 4.8%, Aiforia Technologies −77.5%, Physitrack −40.2%.

More key figures
Free cash flow per share-0.09 EUR
NowFree cash flow per share2022: -0.16222023: -0.14232024: -0.04242025: -0.0625

Cash left after investments, divided by the number of shares.

2022–2025: -0.16 EUR–-0.04 EUR. Peers: Carasent 0.87 SEK, Aiforia Technologies -0.38 EUR, Physitrack 0.03 EUR.

Equity ratio86.1%
2025Equity ratio2022: 85.84222023: 90.03232024: 88.75242025: 86.0625

The percentage of assets financed by shareholders’ equity.

2022–2025: 85.8%–90.0%.

What followed similar falls?

Including reinvested dividends, NordHealth fell 7.5% over the latest five trading days. Since June 4, 2021, falls at least this large were followed by a higher value 21 trading days later in 28 out of 42 non-overlapping periods. The median was +4.1%, against −0.5% for an ordinary 21-day period, which ended higher 46 times in 100.

Such a fall has not said much about the next month.

+4.1% · 28/42

What to watch next, and why

The earnings report shows how NordHealth's revenue and profit have changed.

  • Earnings report

    The earnings report shows how NordHealth's revenue and profit have changed.

    Add to calendar

Earnings report

Next report: · Add to calendar · Google Calendar

Report day2.8%

Normal day2.2%

On its last 9 report days NordHealth usually moved about 2.8%. On a normal day it moves 2.2%.

−2.54% −2.79% −1.45% −3.08%

10,000 NOK in NordHealth bought on June 4, 2021 is worth 6,310 NOK today, with dividends reinvested.

The same amount in OSEBX with dividends would have become 18,100 NOK.

What would 10,000 NOK in NordHealth be worth today? →

What would 10,000 NOK in NordHealth be worth today?

6,310 NOK

with dividends reinvested, bought on June 4, 2021. The same amount in OSEBX with dividends would have become 18,100 NOK.

At worst it was worth 4,130 NOK (May 12, 2022).

The five biggest days of the journey

· +26.3% · the whole market fell 2.6% the same day

· +21.4% · the whole market rose 1.6% the same day

· +17.0% · the whole market rose 2.3% the same day

· +16.2% · the whole market fell 1.3% the same day

· +15.7% · the whole market fell 0.2% the same day

Earlier days

  • −7.52% NordHealth fell clearly over the week's trading days. Read →

    NordHealth fell clearly over the week's trading days.

    The market index fell sharply over the same days, so NordHealth dropped less than the wider market in the last session but moved more across the week.

    The only company news was an announcement that it will report its third-quarter results on Tuesday 10 November 2026, with a presentation at 16:00 CET.

    Such notices contain no new figures and do not by themselves explain a price move.

  • +1.67% NordHealth rose slightly without company news. Read →

    NordHealth rose slightly without company news.

    Over the last five trading days it fell slightly, a bit more than the Oslo Børs benchmark index, which fell clearly.

    The move was an ordinary one for the stock, and trading volume was well above normal.

    No company news explains the session's move.

    The CEO bought shares in early October, which is background only.

  • −9.77% NordHealth fell, far more than Oslo Børs. Read →

    NordHealth fell, far more than Oslo Børs.

    No company news explains the drop.

    Over the last five trading days, the stock fell clearly, while the broader market fell only slightly.

    A move this large was rare for NordHealth in the past year, and trading was heavy.

    Its next earnings report is due Tuesday 10 November 2026, which may help explain the next move.

Learn more · Why do stocks move on earnings day? · Why do stocks go up and down?

All companies